Is migraine an inflammatory event? Which inflammatory markers can we use for migraine?

Aim: It is considered that a relationship exist between migraine and neurogenic inflammation. High levels of tumor necrosis factor,interleukin-6 and C-reactive protein were determined in the studies. The cytoprotective and antioxidant effect of bilirubin has beenshown. Lower serum bilirubin levels have been shown some diseases. For all that, there is no consensus in the results. Our purposein this study is to determine the relationship between migraine and inflammation markers like erythrocyte sedimentation rate,C-reactive protein , bilirubin.Material and Methods: The study included 50 migraine patients and 40 healthy individuals as a control group. Erythrocytesedimentation rate and C-reactive protein, bilirubin parameters, aspartate aminotransferase, alanine aminotransferase wererecorded.Results: Erythrocyte sedimentation rate and C-reactive protein were significantly higher in migraine group. Bilirubin parameters andaspartate aminotransferase , alanine aminotransferase values were similar.Conclusion: Higher serum inflammatory markers support the role of inflammation in migraine pathogenesis. For bilirubin levelslarger cross- sectional studies are needed.

PDF

___

1. Peng YF, Xie LQ, Xiang Y, et al. Serum bilirubin and their association with c- reactive protein in patients with migraine. J Clin Laboratory Anal 2016;30:982-5.
2. Spierings EL. Pathogenesis of the migraine attack. Clin J Pain 2003;19:255- 62.
3. Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006;46:200-7.
4. Lippi G, Mattiuzzi C, Cervellin G. C- reactive protein and migraine. Facts or speculations? Clin Chem Lab Med 2014;52:1265-72.
5. Peng YF, Wei Y, Qin YH, et al. A relationship between migraine undergoing no pharmacological therapy. Clin Chem Lab Med 2016;54:e249-51.
6. Cao L, Xue L, Luo DM. Lower serum bilirubin concentration in patients with migraine. Int J Clin Exp Med 2015;8:13398- 402.
7. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Sci 1987:235:1043-6.
8. Kapitulnik J. Bilirubin: An endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 2004;66:773-9.
9. Tanındı A, Erkan AF, Alhan A, et al. Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin and neutrophil-to- lymphocyte ratio in patients with coronary artery disease. Anadolu Kardiyol Derg 2015;15:396-403.
10. Kawamoto R, Ninomiya D, Hasegawa Y, et al. Association between serum bilirubin and estimated glomerular filtration rate among elderly persons. PLoS One 2014;9:115-294.
11. IHS. The international classification of headache disorders, third edition (beta version). Cephalalgia 2013;33:629-808.
12. Eising E, Datson NA, Maagdenberg AM, et al. Epigenetic mechanisms in migraine: a promising avenue? BMC Med 2013;11:26.
13. Peng F, Deng X, Yu Y, et al. Serum bilirubin concentrations and multipl sclerosis. J Clin Neurosci 2011;18:1355-9.
14. Dos Santos BH, de R Almeida CM, Skare TL. Systemic lupus erythematosus activity and serum bilirubins. Acta Reumatol Port 2013;38:242-6.
15. Fukui M, Tanaka M, Shiraishi E, et al. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 2008;74:1197-201.